SD

Sachin Dnyandev Satpute

Active Director Director DIN 10181395
DIN 10181395 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sachin Dnyandev Satpute

Data last updated:

Sachin Dnyandev Satpute is a Director at Akii Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10181395
Primary Designation Director
Industry Pharma
First Appointment 29 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akii Pharmaceutical Private Limited U21009MH2023PTC403766
Director29 May 20232023Active

Board colleagues of Sachin Dnyandev Satpute

NameDINCompanyDesignation
Nitin Dnyandev Satpute10181396Akii Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Akii Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sachin Dnyandev Satpute

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Dnyandev Satpute

Sachin Dnyandev Satpute currently holds 1 directorship: Akii Pharmaceutical Private Limited (Director, since 29 May 2023).

Sachin Dnyandev Satpute was first appointed on 29 May 2023 as Director at Akii Pharmaceutical Private Limited.

The current boards of Sachin Dnyandev Satpute's companies include Nitin Dnyandev Satpute (Akii Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available